Experimental design for drug development: a bayesian approach

DOI10.1080/10543409108835007zbMath0949.62582OpenAlexW2032336605WikidataQ37151104 ScholiaQ37151104MaRDI QIDQ4216007

Donald A. Berry

Publication date: 7 December 2000

Published in: Journal of Biopharmaceutical Statistics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/10543409108835007

zbMATH Keywords

decision makingdynamic programmingclinical trialspredictive probabilitiesassessing prior probabilities

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Design of statistical experiments (62K99) Bayesian inference (62F15)

Related Items (2)

Optimal Bayesian two-phase designs ⋮ Two useful distributions for Bayesian predicitve procedures under normal models

Cites Work

• One-Sided Sequential Stopping Boundaries for Clinical Trials: A Decision- Theoretic Approach
• Interim Analysis in Clinical Trials: The Role of the Likelihood Principle

This page was built for publication: Experimental design for drug development: a bayesian approach